Announcing HealthGeniuses and ConsumerGeniuses industry blogs with global coverage of digital disruptions
London, United Kingdom May 23, 2022 (Issuewire.com) – IndustryGeniuses, a digital platform for industry innovations, today announced the launch of two new business newsletters HealthGeniuses and ConsumerGeniuses.
HealthGeniuses focuses on the Health care, Pharma, and Life Sciences industry. ConsumerGeniuses focuses on Consumer Goods and FMCG industry. Our blogs and weekly email newsletters curate industry insights, latest trends, and digital disruptions from 150+ top journals and websites from across the globe.
By subscribing to our weekly newsletter, you also get exclusive access to invite-only webinars, networking roundtables with industry trailblazers, and thought-provoking research reports that feature in-depth analyses of industry use cases.
Commenting on the launch of two new blogs, Zeeshan Idrees, CEO of IndustryGeniuses and ex-Salesforce executive, said “We are fast developing IndustryGeniuses as a global platform where industries meet innovation. Through our weekly industry newsletters, roundtables, software advisory service, and go-to-market solutions for tech start-ups and scale-ups, we are redefining how industry trailblazers disrupt their existing business models. The future belongs to brands that can tap into the latest consumer insights and adapt their products, service, supply chain, and go-to-market strategy.”
IndustryGeniuses platform ecosystem brings industry decision-makers, ISV start-ups, Academia, Big Tech, and System Integrator teams all under the same umbrella. This creates unprecedented value for all stakeholders.
For more information and sign up for the weekly email newsletters, please visit IndustryGeniuses.
This article was originally published by IssueWire. Read the original article here.
Disclaimer: The views, suggestions, and opinions expressed here are the sole responsibility of the experts. No THE 2 SIDE STORY journalist was involved in the writing and production of this article.